Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ying Zhao MD"'
Publikováno v:
Technology in Cancer Research & Treatment, Vol 22 (2023)
Background: Systemic inflammatory indicators are clinically significant in guiding diffuse large B-cell lymphoma (DLBCL) prognosis. However, which inflammatory markers are the best predictors of DLBCL prognosis is still unclear. In this study, we aim
Externí odkaz:
https://doaj.org/article/89cd047bd362493c9aacf54fcfcbffa9
Autor:
Chang Liu MD, Ying Zhao MD, Xiaoting Xu MD, PhD, Lei Zhang MD, Fengmei Cui PhD, Qiu Chen PhD, Hongxia Li MD, PhD, Ru Sang MD, PhD, Gen Li PhD, Yongming He MD, PhD
Publikováno v:
Dose-Response, Vol 20 (2022)
The aim is to explore the protective effects of Puerarin on radiation-induced vascular endothelial cell damage and its underlying mechanism. The apoptosis and DNA damage of Human umbilical vascular endothelial cells (HUVECs) exposed to radiation alon
Externí odkaz:
https://doaj.org/article/4c7807afd4eb4629bba3f83288c61f04
Autor:
Cunte Chen MD, Zhuowen Chen MD, Chi Leong Chio MD, Ying Zhao MD, Yongsheng Li MM, Zhipeng Liu MM, Zhenyi Jin MD, Xiuli Wu MD, Wei Wei PhD, Qi Zhao PhD, Yangqiu Li MD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 20 (2021)
Background: Cytogenetics at diagnosis is the most important prognostic factor for adult acute myeloid leukemia (AML), but nearly 50% of AML patients who exhibit cytogenetically normal AML (CN-AML) do not undergo effective risk stratification. Therefo
Externí odkaz:
https://doaj.org/article/a692c929daee4ec78762d83b04da202e
Autor:
Chan Xiang, PhD, Wei Zhang, PhD, MD, Li-Wen Xiong, MD, Xu-Wei Cai, PhD, MD, Hao-Hua Teng, MD, Rui-Ying Zhao, MD, Zhan-Xian Shang, MD, Han Han-Zhang, PhD, Lu Zhang, PhD, Li Yan, MS, Zhi-Qiu Chen, MS, Yu-Chen Han, PhD, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 7, Pp 100185- (2021)
Introduction: It has been well established that EGFR Thr790Met is one of the major resistance mechanisms to first- and second-generation EGFR tyrosine kinase inhibitors (TKIs). Nevertheless, whether EGFR Thr790Leu (T790L), which shares the mutation s
Externí odkaz:
https://doaj.org/article/7fd26607f3e34a41914b0c4f30acf3e8